Healixa Inc.
EMOR · OTC
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $39 | $61 | $25 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $7 | $7 | $7 | $7 |
| Enterprise Value | $14 | $46 | $68 | $32 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 323.6% | -76.4% | 204.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69% | 12.6% | 69% | 6.8% |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 9.7% | -154.3% | 7.6% | -133% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13.2% | -154.3% | -13.2% | -165.5% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 50% | -100% | 66.7% | – |
| Operating Cash Flow | -$0 | – | -$0 | -$0 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | -$0 | – | -$0 | -$0 |